Back to top

Analyst Blog

Zacks Equity Research

Omnicell Widens Customer Base

OMCL CFN

 ZacksTrade Now

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Omnicell Inc. (OMCL - Analyst Report), provider of end-to-end automated solutions for medication-use process, has expanded its customer base as Springhill Medical Center selected it as its exclusive provider for medication management solutions. Mobile, Alabama-based Springhill Medical Center is a hospital with 252 beds.

Omnicell serves a niche market that is expected to grow further as it continues to gain more clients. With the growing demand for more efficient medication administration, Springhill Medical Center will deploy Omnicell’s G4 and Anywhere RN remote medication management system to better manage its hospital.

The decentralized pharmacy model on G4 platform is expected to result in reallocation of nursing hours in patient care. This should lead to improvement in the hospital’s operations and nursing workflow. Moreover, the hospital expects to increase standards of patient care with a less labor-intensive method of medication management.

In a bid to standardize its management solutions, the hospital will also deploy Omnicell’s well-regarded Pandora business analytics solutions. Pandora analytics will provide valuable insights into the clinical operations of the hospital and curtail medication-associated administrative errors.

Currently, an increasing number of institutions are planning to shift to the automated mode to improve workflow and medication management. Further, the shortage of nursing facilities in the U.S. should drive demand for automated solutions for medication and supply solutions.

Omnicell also stands to benefit from demographic tailwinds as well as higher investment in the healthcare industry. However, lower capital expenditure by hospitals as they battle reimbursement cuts and budget constraints remains a looming concern for the company.

We currently have a long-term Neutral recommendation on the stock which carries a Zacks Rank #3 (Hold). CareFusion Corporation (CFN - Analyst Report), a major player in the medication management and supply chain solutions market, carries a Zacks Rank #2 (Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GRP IN DXYN 15.84 +7.90%
BOFI HLDG IN BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%